How does erythromycin affect individuals with renal impairment and what adjustments in dosage or monitoring are necessary to prevent toxicity or ensure therapeutic effectiveness?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Erythromycin is metabolized primarily by the liver, not kidneys. In patients with renal impairment, dose adjustments are generally not necessary. However, monitoring for liver toxicity is advised.